Manuel Suárez‐Tembra

Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia

Sofía Pérez‐Calahorra, Martín Laclaustra, Victoria Marco-Benedí et al. · Atherosclerosis · 2019 · 62 citations · Full text

Metabolic Syndrome, Lipid-lowering Treatment, Familial Hypercholesterolemia +12

Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population

Juan F. Ascaso, Jesús Millán, Rocío Mateo‐Gállego et al. · European Journal of Internal Medicine · 2011 · 36 citations · Full text

Obesity, Metabolic Syndrome, Hypertension +11

Behavioural cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolaemia

Sofía Pérez‐Calahorra, Fernando Civeira, Pilar Guallar‐Castillón et al. · European Journal of Preventive Cardiology · 2020 · 30 citations · Full text

How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?

L. Masana, Núria Plana, Sofía Pérez‐Calahorra et al. · Atherosclerosis · 2017 · 20 citations · Full text

Metabolic Syndrome, Cardiovascular Disease, Pcsk9 Inhibition +7

Screening of APOB Gene Mutations in Subjects with Clinical Diagnosis of Familial Hypercholesterolemia

Erardo Meriño-Ibarra, Sergio Castillo, Pilar Mozas et al. · Human Biology · 2005 · 15 citations

Genetic Testing, Genetics, Genetic Epidemiology +17